{"mainPropery":{"diseaseId":8452,"diseaseName":"Tièche-Jadassohn nevus","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8452/tieche-jadassohn-nevus","synonyms":["Jadassohn-Tièche nevus","Jadassohn-Tièche syndrome","Benign mesenchymal melanoma","Blue neuronevus","Blue nevus"],"synonyms-with-source":[{"name":"Jadassohn-Tièche nevus"},{"name":"Jadassohn-Tièche syndrome"},{"name":"Benign mesenchymal melanoma"},{"name":"Blue neuronevus"},{"name":"Blue nevus"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C0206736"}]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MESH:D018329' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/melanoma' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":121,"genericName":"Aldesleukin","tradeName":"Proleukin","tradeLink":"https://www.proleukin.com/","manufacturer":"","sponsor":"Chiron Corporation","indication":"Treatment of adults with metastatic melanoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/Proleukin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a692009.html"}],"EncodedName":"Ti%C3%A8che-Jadassohn_nevus"}